FTC cracks down on DaVita's market power

  • 📰 axios
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The Federal Trade Commission has the dialysis industry in its crosshairs after it finalized restrictions on DaVita's latest deal in Utah.

agreement

allows DaVita to purchase 18 dialysis clinics owned by University of Utah Health, but three acquired clinics in the Provo, Utah area must be divested. DaVita also can't buy another clinic in Utah for 10 years unless it gets prior FTC approval, nor can it prevent employees at the acquired clinics from jumping to jobs at competing dialysis clinics.

If the FTC didn't impose these conditions, DaVita would have owned seven of the eight dialysis clinics in the Provo area.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 302. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인